Novel anti-Acanthamoebic properties of raloxifene sulfonate/sulfamate derivatives

Copyright © 2023 Elsevier B.V. All rights reserved..

Acanthamoeba are known to cause a vision threatening eye infection typically due to contact lens wear, and an infection of the central nervous system. The ability of these amoebae to switch phenotypes, from an active trophozoite to a resistant cyst form is not well understood; the cyst stage is often resistant to chemotherapy, which is of concern given the rise of contact lens use and the ineffective disinfectants available, versus the cyst stage. Herein, for the first time, a range of raloxifene sulfonate/sulfamate derivatives which target nucleotide pyrophosphatase/phosphodiesterase enzymes, were assessed using amoebicidal and excystation tests versus the trophozoite and cyst stage of Acanthamoeba. Moreover, the potential for cytopathogenicity inhibition in amoebae was assessed. Each of the derivatives showed considerable anti-amoebic activity as well as the ability to suppress phenotypic switching (except for compound 1a). Selected raloxifene derivatives reduced Acanthamoeba-mediated host cell damage using lactate dehydrogenase assay. These findings suggest that pyrophosphatase/phosphodiesterase enzymes may be valuable targets against Acanthamoeba infections.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:256

Enthalten in:

Molecular and biochemical parasitology - 256(2023) vom: 09. Dez., Seite 111582

Sprache:

Englisch

Beteiligte Personen:

Siddiqui, Ruqaiyyah [VerfasserIn]
El-Gamal, Mohammed I [VerfasserIn]
Sajeev, Sreedevi [VerfasserIn]
Zaraei, Seyed-Omar [VerfasserIn]
Khan, Naveed Ahmed [VerfasserIn]

Links:

Volltext

Themen:

4F86W47BR6
9NFU33906Q
Acanthamoeba
Alkanesulfonates
Anti-amoebic
CNS infections
EC 3.1.4.-
Free-living amoebae
Journal Article
Phosphoric Diester Hydrolases
Raloxifene Hydrochloride
Raloxifene derivatives
Sulfamic acid
Sulfonic Acids

Anmerkungen:

Date Completed 16.12.2023

Date Revised 12.03.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.molbiopara.2023.111582

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360621333